You already know that lung cancer can develop in someone who has never smoked a cigarette and that the disease is linked to lifestyle risk factors, like exposure to radon and asbestos. The good news is that there are many positive habits you can adopt to significantly lower your cancer risk. According to a 2010 study in the journal Cancer Letters, lifestyle has a significant impact on whether or not you develop a variety of cancers, including lung cancer. Changing the way you live, including what you eat, whether you exercise or not, and what you are exposed to in your day-to-day environment can make a huge difference in your level of risk.
Oncimmune (LON:ONC) is a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer. Oncimmune is changing how clinicians, researchers and patients view, diagnose and treat cancer. Our technology detects evidence of the body’s natural response to cancer, enabling detection 4 years or more before standard clinical diagnosis. Our tests facilitate clinical decision-making and are complementary to diagnostic technologies, making them valuable additions to established and new care pathways. We partner with leading developers and distributors to make our technology available globally.
